PYX Resources: Achieving volume and diversification milestones. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
What agenda?
I bought in to the CPT story back when we were launching in to China and in the end I wished I'd never heard of CPT. They have been an absolute disaster and anyone who says otherwise is deluding themselves. Maybe they will make a success of it and maybe they won't but nobody can claim that this hasn't been a car crash.
Curioser where in the RNS does it state that it is the only quantitative home test made in the UK by a publicly listed company? It is a lie pure and simple. Are you serious telling me that the company wouldn't be aware of a competitor selling the same product? They are trying to mislead people in to thinking that they have a unique product when they don't.
agenda and for some time now
It's based in US, we are based in UK so it's TRUE in our market, plus it's a private company, seriously why are there so many literalists on this chat, SEE chat is just a whole level up, up and beyond the bizarre comments that get posted here
Just for info for anyone who is thinking of buying into this, today's RNS release contains a blatant lie.
They said and I quote:
"myLotus® enables women to monitor their fertile phase as part of their menstrual cycle and is the only home test to 'quantitatively' measure hormone levels and the 'rate-of-change' of these levels preceding ovulation to help aid a natural conception."
Go to https://www.miracare.com/ and you will see that this is a lie. Another product that does exactly the same thing and has CE marking and FDA approval.
After all that we've been through with this stock, now is the point people are actually jumping? I might be missing something but seems to me this is the news we've all been waiting for. Give it 6 months and the books will be looking as hot as we always anticipated and then some. If people can spend £1000+ on a pushchair, do you really think £300 is too much for them to pay on helping to conceive. I know people who fly internationally just to meet doctors who can possibly help them. If you're leaving, make it quick so we can stabilise our stock prices. If you're staying, hold on tight.....its going to be a bumpy ride! The above is not financial advice, just my ramblings so take care of your own investments
Er indoors would have spent 99k!!!! Money does not feature in this product. Its whether they think it works and rumour has it does. Watch the episodes of 'Fools and Horses' because it is so real.
is one thing selling the c£300 product is another ball game altogether. If they dont shift the units, I would guess they will loose the shelf space
This needs to be a ~£99 price point to be popular with the masses IMHO
I am holding these. Whilst I might regret it I have been involved with a broody woman and money counts for nothing. Buying on of these should buy a man a few moths respite and hey ho it might work!!
to see all the new posters' 'positivity ;-)
Fwiw TW's take on this is that it is massive and other retailers will now follow. "Make no mistake this deal is massive, get on board at 5.5p or less while you can." And his target is 10p+ "before very long indeed". And, for once, he may well be right on this one.
games going on...shake,shake..
Hopefully investors will digest update and realize that there is a market for this product
FOMO and updates/newsflow should help CPT rise from this low
DYOR
Cheers Crusader fully in agreement with you, thank you.
Copiable
Crusader, while the electronic box is capable, the chemical assays are not even by reverse engineering, I imagine the Chinese will take another look at this once it takes off in the west tbh
babs,
Don't worry about China. They are now probably making their own after dissembling the one they were given, No kidding. China doesn't give a hoot about proprietary information hence all the trade talks. And even if there is finally an agreement, it will mean diddly squat. They want international rules to protect them but don't recognise any when the rules go against them. Lucky MyLoytus is not sold from an Island in the South China Sea.....LOL
'The Company expects to release further hormone health and wellbeing tests to complement its fertility offering later this year.'
This an EU, US rollout will make us a good takeover target, it's a mature product, excellent rns
A few years ago I bought this at 18p following a Mail on Sunday tip. It proved to be crap like the rest of their tips. Surprised it is still going.
Wait wait and more waiting.....what’s the deal, when, numbers, publicity, when is the EU expected. The communications here are poor even with a new man in charge, not awe inspiring are they. Investors will no doubt make their own mind up. I am beyond wishing holders well. Never any meat in the bone.
Cannot see this causing a rerate without any supporting financial details. At least we know they are doing something but fully expect another bout of dilution just around the corner.
might dump on any rise today in my opinion.
don't these guys need to raise?
traction being gained..
Steady rollout across UK and Europe..
Onwards and upwards imho
DYOR
Concepta Plc secures partnership with Walgreens Boots Alliance!!
Peter Dines, Chief Operating Officer at Mercia and a non-executive director of Concepta, said: "Securing a partnership with such a leading retailer as Walgreens Boots Alliance is validation that Concepta has developed a product with significant commercial appeal. This new partnership will play a pivotal role in myLotus® being more widely available across the UK and overseas."
"Concepta to supply myLotus® to Walgreens Boots"
https://www.investegate.co.uk/concepta-plc--cpt-/rns/concepta-to-supply-mylotus--to-walgreens-boots/201903120700225654S/
Encouraging RNS, a nice shot in the arm !
it's a bit recycled from the earlier Boots agreement but better than nothing!
150 women - hmmm
150,000 is what's required for profitability!